Definition
What Is Regenerative Medicine?
再生医療は組織修復、機能回復、細胞治療、エクソソーム研究、組織工学、再生科学を含む分野です。単一の治療やアンチエイジングサービスとして単純化すべきではありません。


Medical Risk Statement
再生医療は急速に進化する分野です。すべての治療法が同じ科学的根拠を持つわけではありません。適合性、リスク、利益、規制上の論点は患者、医療機関、国や地域によって異なります。医療判断は資格ある医師と相談して行う必要があります。
Definition
再生医療は組織修復、機能回復、細胞治療、エクソソーム研究、組織工学、再生科学を含む分野です。単一の治療やアンチエイジングサービスとして単純化すべきではありません。
AETERA Position
再生医療には好奇心、慎重さ、情報に基づく判断が必要です。AETERAの役割は治療を推奨することではなく、選択肢を理解し長期的な健康判断を支えることです。
Understand cell therapy concepts, suitability, regulatory documentation, and risk boundaries before considering any program.
Read more
Review extracellular vesicle and exosome discussions as a scientific field, not as a guaranteed treatment claim.
Read more
Place tissue repair, biomaterials, cells, and regenerative science inside an evidence and clinical-use framework.
Read more
Separate established practice, emerging applications, investigational studies, and early-stage concepts.
Read more
Review institution standards, physician responsibility, documentation, adverse-event planning, and jurisdictional rules.
Read more
Evidence
| Evidence Level | Description |
|---|---|
| Established Clinical Practice | Widely used within appropriate indications and supported by mature clinical standards. |
| Emerging Clinical Applications | Growing evidence, but suitability and standards still require careful physician assessment. |
| Investigational Research | Limited or study-specific evidence; should be understood through research design and consent. |
| Experimental Concepts | Early-stage ideas that should not be presented as routine care or guaranteed outcomes. |
Japan
日本には再生医療に関する規制枠組みがあります。医療機関は該当する規制要件に従う必要があり、手技、施設、適用規則によって扱いは異なります。適合性は医師が判断します。
Suitability
必ずしもそうではありません。年齢、既往歴、診断、目的、医師評価が適合性に影響します。AETERAは再生医療がすべての人に適しているとは前提しません。
Decision Framework
Understand the objective
Review medical history
Assess available evidence
Evaluate institutional standards
Discuss risks and limitations
Coordinate information gathering
Support informed decision-making
Regenerative medicine is a field that studies tissue repair, functional recovery, cellular mechanisms, and regenerative science. It is not a single treatment or a guaranteed anti-aging solution.
Stem cell therapy refers to medical or research approaches that use cells or cell-related mechanisms. Suitability, evidence, cell source, processing standards, and regulatory documentation must be reviewed carefully.
Exosomes are extracellular vesicles involved in cell communication. They are widely discussed in research, but clinical claims require careful review of evidence, preparation standards, and applicable regulation.
No. Age, diagnosis, medical history, treatment goals, contraindications, and physician assessment all influence suitability.
Suitability is evaluated through medical history, current diagnosis, laboratory and imaging data, risk factors, goals, alternative options, and physician judgment.
Ask about evidence level, indication, expected benefit, risks, alternatives, physician credentials, institution standards, regulatory documents, follow-up, and adverse-event management.
Risks vary by procedure and patient. They may include infection, immune reaction, inappropriate indication, poor-quality preparation, uncertain benefit, delayed standard care, or inadequate follow-up.
Japan has regulatory frameworks related to regenerative medicine. The status of a specific procedure depends on the procedure, institution, physician responsibility, documentation, and applicable rules.
It should not be simplified that way. The regulatory status depends on the specific procedure, institution, and applicable regulations.
No. AETERA provides education, coordination, record preparation, and decision support. Medical advice, diagnosis, and treatment decisions must come from qualified physicians.
No. AETERA does not guarantee outcomes, reverse aging claims, cure claims, or suitability for any regenerative medicine option.
No. AETERA's role is not to promote treatments. Our role is to help clients understand options, risks, evidence, and decision pathways.
Relevant documents may include medical records, lab reports, imaging, medication history, consent forms, institution materials, physician background, regulatory documentation, and follow-up plans.
Evidence levels help clients distinguish mature clinical practice from emerging applications, investigational research, and early-stage concepts.
A Medical Family Office helps organize information, ask better questions, review risk boundaries, coordinate qualified opinions, and support long-term family health decisions.
AETERA helps families turn complex regenerative medicine information into a clearer, physician-led decision pathway.
プライベート相談